Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New concepts in ischemia prevention.

W Klein1, B Eber, J Dusleag

  • 1Department of Internal Medicine, Karl Franzens University, Graz, Austria.

Journal of Cardiovascular Pharmacology
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multicenter Evaluation of the Clinical Performance and the Neutralizing Antibody Activity Prediction Properties of 10 High-Throughput Serological Assays Used in Clinical Laboratories.

Journal of clinical microbiology·2020
Same author

Oral loading of propafenone: restoring its role before restoring rhythm-authors' reply.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2017
Same author

Socio-economic effects and cost saving potential of remote patient monitoring (SAVE-HM trial).

International journal of cardiology·2014
Same author

[Diabetes and osteoporosis: pathophysiological interactions and clinical importance for geriatric patients].

Zeitschrift fur Gerontologie und Geriatrie·2013
Same author

Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management.

Wiener klinische Wochenschrift·2012
Same author

Inflammation, adiponectin, obesity and cardiovascular risk.

Current medicinal chemistry·2010

Calcium channel blockers effectively reduce myocardial ischemia in coronary heart disease patients. However, caution is advised for those with postinfarction left ventricular dysfunction, with specific agents requiring combination therapy for optimal results.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Transient myocardial ischemia stems from coronary artery obstruction or diminished flow reserve.
  • Calcium channel blockers are used for stress-induced ischemia in coronary heart disease.
  • Concerns exist regarding calcium antagonists in postinfarction left ventricular systolic dysfunction.

Purpose of the Study:

  • To evaluate the efficacy of calcium antagonists in managing myocardial ischemia.
  • To compare different classes of calcium antagonists and their effects on ischemic burden.
  • To explore the role of ACE inhibitors in ischemia and hypertrophy.

Main Methods:

  • Review of existing studies on calcium antagonists and ACE inhibitors in myocardial ischemia.
  • Analysis of drug effects based on heart rate changes and combination therapy.

Related Experiment Videos

  • Consideration of ischemic threshold for individualized treatment strategies.

    • Main Results:

    • Calcium antagonists reduce stress-induced ischemia in patients with normal or reduced left ventricular function.
    • Diltiazem (rate-reducing) effectively reduces ischemic burden as monotherapy.
    • Dihydropyridines (rate-increasing) require beta-blocker combination for similar effects.
    • ACE inhibitors show no significant benefit in stress-induced ischemia but may reduce total burden.
    • Calcium blockers and ACE inhibitors may regress left ventricular and vascular hypertrophy, but ischemia reduction is unproven.

    Conclusions:

    • Calcium channel blockers are beneficial for stress-induced ischemia, with specific considerations for heart rate effects and patient conditions.
    • Individualized therapy based on ischemic threshold is crucial for 24-hour ischemia control.
    • Further research is needed to confirm the anti-ischemic effects of ACE inhibitors and calcium blockers in specific hypertrophic conditions.